BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36655324)

  • 1. Effects of dynamic contrast enhancement on transition zone prostate cancer in Prostate Imaging Reporting and Data System Version 2.1.
    Zhang J; Xu L; Zhang G; Zhang X; Bai X; Sun H; Jin Z
    Radiol Oncol; 2023 Mar; 57(1):42-50. PubMed ID: 36655324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.
    Schimmöller L; Quentin M; Arsov C; Hiester A; Buchbender C; Rabenalt R; Albers P; Antoch G; Blondin D
    Eur Radiol; 2014 Oct; 24(10):2582-9. PubMed ID: 24972954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
    Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
    Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of multiparametric MRI with histopathological grade of peripheral zone prostate carcinoma.
    Singla A; Deep N; Naik S; Mohakud S; Nayak P; Sable M
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S569-S576. PubMed ID: 38384020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.
    Bura V; Caglic I; Snoj Z; Sushentsev N; Berghe AS; Priest AN; Barrett T
    Eur Radiol; 2021 Jul; 31(7):4908-4917. PubMed ID: 33398421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
    Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
    Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Prostate Imaging Reporting and Data System for Magnetic Resonance Imaging Diagnosis of Prostate Cancer in Patients with Prostate-specific Antigen <20 ng/ml.
    Wang X; Wang JY; Li CM; Zhang YQ; Wang JL; Wan B; Zhang W; Chen M; Li SY; Wan G; Liu M
    Chin Med J (Engl); 2016 Jun; 129(12):1432-8. PubMed ID: 27270538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
    Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
    Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-based analysis of different clinically significant prostate cancer detection rate of prostate imaging reporting and data system score 4 in the peripheral zone.
    Sun Z; Wang H; Fu W; Zhu S; Song G
    Abdom Radiol (NY); 2023 Jan; 48(1):390-398. PubMed ID: 36305943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are T2WI PI-RADS sub-scores of transition zone prostate lesions biased by DWI information? A multi-reader, single-center study.
    Zhang KS; Mayer P; Glemser PA; Tavakoli AA; Keymling M; Rotkopf LT; Meinzer C; Görtz M; Kauczor HU; Hielscher T; Stenzinger A; Bonekamp D; Hohenfellner M; Schlemmer HP
    Eur J Radiol; 2023 Oct; 167():111026. PubMed ID: 37639843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of prostatitis and prostate cancer using the Prostate Imaging-Reporting and Data System (PI-RADS).
    Meier-Schroers M; Kukuk G; Wolter K; Decker G; Fischer S; Marx C; Traeber F; Sprinkart AM; Block W; Schild HH; Willinek W
    Eur J Radiol; 2016 Jul; 85(7):1304-11. PubMed ID: 27235878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of dynamic contrast enhancement on diffusion weighted imaging score of 3 in prostate imaging reporting and data system version 2 of peripheral zone].
    Wang W; Shao ZH; Huang XH; Xu Y; Feng X; Wang PJ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1002-1006. PubMed ID: 32294857
    [No Abstract]   [Full Text] [Related]  

  • 15. Is contrast enhancement needed for diagnostic prostate MRI?
    Scialpi M; Rondoni V; Aisa MC; Martorana E; D'Andrea A; Malaspina CM; Orlandi A; Galassi G; Orlandi E; Scialpi P; Dragone M; Palladino D; Simeone A; Amenta M; Bianchi G
    Transl Androl Urol; 2017 Jun; 6(3):499-509. PubMed ID: 28725592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Dynamic Contrast-Enhanced (DCE) MR Imaging in Peripheral Lesions in PI-RADS-4 Patients.
    Ullrich T; Quentin M; Arsov C; Laqua N; Abrar D; Hiester A; Albers P; Antoch G; Schimmöller L
    Rofo; 2020 May; 192(5):441-447. PubMed ID: 31622990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
    Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
    World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
    Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
    Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary study of combining T2-weighted imaging, diffusion weighted imaging and dynamic contrast enhanced-magnetic resonance imaging for diagnosing prostatic central gland cancer].
    Li P; Yang W; Chen Z; Guo Y; Cai L; Du Y; Li Y
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2448-51. PubMed ID: 25400054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.
    Vargas HA; Hötker AM; Goldman DA; Moskowitz CS; Gondo T; Matsumoto K; Ehdaie B; Woo S; Fine SW; Reuter VE; Sala E; Hricak H
    Eur Radiol; 2016 Jun; 26(6):1606-12. PubMed ID: 26396111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.